α7 nicotinic acetylcholine receptor interaction with G proteins in breast cancer cell proliferation, motility, and calcium signaling
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0289098 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Murat Oz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, College of Pharmacy, Kuwait University, Safat, Kuwait. Hauptthemen laut MEDLINE: Breast Neoplasms, Receptors, Nicotinic, Heterotrimeric GTP-Binding Proteins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kuwait Foundation for the Advancement of Sciences.
Abstract (Originalsprache)
Chronic smoking is a primary risk factor for breast cancer due to the presence of various toxins and carcinogens within tobacco products. Nicotine is the primary addictive component of tobacco products and has been shown to promote breast cancer cell proliferation and metastases. Nicotine activates nicotinic acetylcholine receptors (nAChRs) that are expressed in cancer cell lines. Here, we examine the role of the α7 nAChR in coupling to heterotrimeric G proteins within breast cancer MCF-7 cells. Pharmacological activation of the α7 nAChR using choline or nicotine was found to increase proliferation, motility, and calcium signaling in MCF-7 cells. This effect of α7 nAChR on cell proliferation was abolished by application of Gαi/o and Gαq protein blockers. Specifically, application of the Gαi/o inhibitor pertussis toxin was found to abolish choline-mediated cell proliferation and intracellular calcium transient response. These findings were corroborated by expression of a G protein binding dominant negative nAChR subunit (α7 345-348A ), which resulted in significantly attenuating calcium signaling and cellular proliferation in response to choline. Our study shows a new role for G protein signaling in the mechanism of α7 nAChR-associated breast cancer growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Therapeutics, College of Pharmacy, Kuwait University, Safat, Kuwait.
- Interdisciplinary Program in Neuroscience, George Mason University, Fairfax, Virginia, United States of America.
- Department of Biological Sciences, Schmid College of Science and Technology, Chapman University, Orange, California, United States of America.
- School of Systems Biology George Mason University, Fairfax, Virginia, United States of America.
ORCID-Profile: Nadine Kabbani
Förderung
- Kuwait Foundation for the Advancement of Sciences
Zitieren
APA
Oz, M., King, J. R., Yang, K. S., Khushaish, S., Tchugunova, Y., Khajah, M. A., Luqmani, Y. A., & Kabbani, N. (2023). α7 nicotinic acetylcholine receptor interaction with G proteins in breast cancer cell proliferation, motility, and calcium signaling. PLOS ONE. https://doi.org/10.1371/journal.pone.0289098
Vancouver
Oz M, King JR, Yang KS, Khushaish S, Tchugunova Y, Khajah MA, et al. α7 nicotinic acetylcholine receptor interaction with G proteins in breast cancer cell proliferation, motility, and calcium signaling. PLOS ONE. 2023. doi:10.1371/journal.pone.0289098
BibTeX
@article{Oz2023,
author = {Oz, Murat and King, Justin R and Yang, Keun-Hang Susan and Khushaish, Sarah and Tchugunova, Yulia and Khajah, Maitham A and Luqmani, Yunus A and Kabbani, Nadine},
title = {α7 nicotinic acetylcholine receptor interaction with G proteins in breast cancer cell proliferation, motility, and calcium signaling},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0289098}
}
EUVIMED